Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry

Journal of Proteome Research

Volumn 7, Issue 12, 2008, Pages 5314-5326

  Zanivan, Sara ^a   Gnad, Florian ^a   Wickström, Sara A ^a   Geiger, Tami ^a   Macek, Boris ^a   Cox, Jürgen ^a   Fässler, Reinhard ^a   Mann, Matthias ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Frozen tissues; Mass spectrometry; Phosphorylation; Solid tumors

Indexed keywords

COMPLEMENTARY DNA; PHOSPHOPROTEIN; PROTEOME; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; DNA MICROARRAY; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SKIN TUMOR; SOLID TUMOR; TUMOR MODEL;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; MELANOMA; MICE; NEOPLASM PROTEINS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; PHOSPHORYLATION; PROTEOMICS;

MUS;

EID: 61349150575     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800599n     Document Type: Article

References (87)

1. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100 (1), 57-70.
2. Dhillon, A. S.; Hagan, S.; Rath, O.; Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26 (22), 3279-90.
3. Martin, G. S. Cell signaling and cancer. Cancer Cell 2003, 4 (3), 167-74.
4. Abramovitz, M.; Leyland-Jones, B. Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatment. Cancer Genomics Proteomics 2007, 4 (3), 135-45.
5. Moasser, M. M. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 2007, 26 (45), 6469-87.
6. Liang, P.; Pardee, A. B. Analysing differential gene expression in cancer. Nat. Rev. Cancer 2003, 3 (11), 869-76.
7. Cowell, J. K.; Hawthorn, L. The application of microarray technology to the analysis of the cancer genome. Curr. Mol. Med. 2007, 7 (1), 103-20.
8. Culp, W. D.; Neal, R.; Massey, R.; Egevad, L.; Pisa, P.; Garland, D. Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model. J. Proteome Res. 2006, 5 (6), 1332-43.
9. Neri, D.; Bicknell, R. Tumour vascular targeting. Nat. Rev. Cancer 2005, 5 (6), 436-46.
10. Hanash, S. Disease proteomics. Nature 2003, 422 (6928), 226-32.
11. Dalton, W. S.; Friend, S. H. Cancer biomarkers - an invitation to the table. Science 2006, 312 (5777), 1165-8.
12. Nevins, J. R.; Potti, A. Mining gene expression profiles: expression signatures as cancer phenotypes. Nat. Rev. Genet. 2007, 8 (8), 601-9.
13. McDonald, W. H.; Yates, J. R., III. Shotgun proteomics and biomarker discovery. Dis. Markers 2002, 18 (2), 99-105.
14. Celis, J. E.; Gromov, P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003, 3 (1), 9-15.
15. Celis, J. E.; Celis, P.; Ostergaard, M.; Basse, B.; Lauridsen, J. B.; Ratz, G.; Rasmussen, H. H.; Orntoft, T. F.; Hein, B.; Wolf, H.; Celis, A. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Cancer Res. 1999, 59 (12), 3003-9.
16. Chen, G.; Gharib, T. G.; Huang, C. C.; Thomas, D. G.; Shedden, K. A.; Taylor, J. M.; Kardia, S. L.; Misek, D. E.; Giordano, T. J.; Iannettoni, M. D.; Orringer, M. B.; Hanash, S. M.; Beer, D. G. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 2002, 8 (7), 2298-305.
17. Blume-Jensen, P.; Hunter, T. Oncogenic kinase signalling. Nature 2001, 411 (6835), 355-65.
18. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422 (6928), 198-207.
19. Cox, J.; Mann, M. Is proteomics the new genomics. Cell 2007, 130 (3), 395-8.
20. Jensen, O. N. Interpreting the protein language using proteomics. Nat. Rev. Mol. Cell Biol. 2006, 7 (6), 391-403.
21. Olsen, J. V.; Blagoev, B.; Gnad, F.; Macek, B.; Kumar, C.; Mortensen, P.; Mann, M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127 (3), 635-48.
22. Villen, J.; Beausoleil, S. A.; Gerber, S. A.; Gygi, S. P. Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (5), 1488-93.
23. Witze, E. S.; Old, W. M.; Resing, K. A.; Ahn, N. G. Mapping protein post-translational modifications with mass spectrometry. Nat. Methods 2007, 4 (10), 798-806.
24. Rush, J.; Moritz, A.; Lee, K. A.; Guo, A.; Goss, V. L.; Spek, E. J.; Zhang, H.; Zha, X. M.; Polakiewicz, R. D.; Comb, M. J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23 (1), 94-101.
25. Rikova, K.; Guo, A.; Zeng, Q.; Possemato, A.; Yu, J.; Haack, H.; Nardone, J.; Lee, K.; Reeves, C.; Li, Y.; Hu, Y.; Tan, Z.; Stokes, M.; Sullivan, L.; Mitchell, J.; Wetzel, R.; Macneill, J.; Ren, J. M.; Yuan, J.; Bakalarski, C. E.; Villen, J.; Kornhauser, J. M.; Smith, B.; Li, D.; Zhou, X.; Gygi, S. P.; Gu, T. L.; Polakiewicz, R. D.; Rush, J.; Comb, M. J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131 (6), 1190-203.
26. Pollock, P. M.; Cohen-Solal, K.; Sood, R.; Namkoong, J.; Martino, J. J.; Koganti, A.; Zhu, H.; Robbins, C.; Makalowska, I.; Shin, S. S.; Marin, Y.; Roberts, K. G.; Yudt, L. M.; Chen, A.; Cheng, J.; Incao, A.; Pinkett, H. W.; Graham, C. L.; Dunn, K.; Crespo-Carbone, S. M.; Mackason, K. R.; Ryan, K. B.; Sinsimer, D.; Goydos, J.; Reuhl, K. R.; Eckhaus, M.; Meltzer, P. S.; Pavan, W. J.; Trent, J. M.; Chen, S. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat. Genet. 2003, 34 (1), 108-12.
27. Rappsilber, J.; Ishihama, Y.; Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003, 75 (3), 663-70.
28. Macek, B.; Mijakovic, I.; Olsen, J. V.; Gnad, F.; Kumar, C.; Jensen, P. R.; Mann, M. The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol. Cell Proteomics 2007, 6 (4), 697-707.
29. Pinkse, M. W.; Uitto, P. M.; Hilhorst, M. J.; Ooms, B.; Heck, A. J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem. 2004, 76 (14), 3935-43.
30. Rappsilber, J.; Mann, M.; Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2007, 2 (8), 1896-906.
31. Olsen, J. V.; Ong, S. E.; Mann, M. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol. Cell. Proteomics 2004, 3 (6), 608-14.
32. Schroeder, M. J.; Shabanowitz, J.; Schwartz, J. C.; Hunt, D. F.; Coon, J. J. A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. Anal. Chem. 2004, 76 (13), 3590-8.
33. Olsen, J. V.; de Godoy, L. M.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 2005, 4 (12), 2010-21.
34. Perkins, D. N.; Pappin, D. J.; Creasy, D. M.; Cortrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20 (18), 3551-67.
35. Zubarev, R.; Mann, M. On the proper use of mass accuracy in proteomics. Mol. Cell. Proteomics 2007, 6 (3), 377-81.
36. Gnad, F.; Ren, S.; Cox, J.; Olsen, J. V.; Macek, B.; Oroshi, M.; Mann, M. PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol. 2007, 8 (11), R250.
37. Birney, E.; rews, T. D.; Bevan, P.; Caccamo, M.; Chen, Y.; Clarke, L.; Coates, G.; Cuff, J.; Curwen, V.; Cutts, T.; Down, T.; Eyras, E.; Fernandez-Suarez, X. M.; Gane, P.; Gibbins, B.; Gilbert, J.; Hammond, M.; Hotz, H. R.; Iyer, V.; Jekosch, K.; Kahari, A.; Kasprzyk, A.; Keefe, D.; Keenan, S.; Lehvaslaiho, H.; McVicker, G.; Melsopp, C.; Meidl, P.; Mongin, E.; Pettett, R.; Potter, S.; Proctor, G.; Rae, M.; Searle, S.; Slater, G.; Smedley, D.; Smith, J.; Spooner, W.; Stabenau, A.; Stalker, J.; Storey, R.; Ureta-Vidal, A.; Woodwark, K. C.; Cameron, G.; Durbin, R.; Cox, A.; Hubbard, T.; Clamp, M. An overview of Ensembl. Genome Res. 2004, 14 (5), 925-8.
38. Dowell, R. D.; Jokerst, R. M.; Day, A.; Eddy, S. R.; Stein, L. The distributed annotation system. BMC Bioinf. 2001, 2, 7.
39. Finn, R. D.; Stalker, J. W.; Jackson, D. K.; Kulesha, E.; Clements, J.; Pettett, R. ProServer: a simple, extensible Perl DAS server. Bioinformatics 2007, 23 (12), 1568-70.
40. Maere, S.; Heymans, K.; Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21 (16), 3448-9.
41. Graumann, J.; Hubner, N. C.; Kim, J. B.; Ko, K.; Moser, M.; Kumar, C.; Cox, J.; Schoeler, H.; Mann, M. SILAC-labeling and proteome quantitation of mouse embryonic stem cells to a depth of 5111 proteins. Mol. Cell. Proteomics 2008, 7, 672-83.
42. Berrier, A. L.; Yamada, K. M. Cell-matrix adhesion. J. Cell Physiol. 2007, 213 (3), 565-73.
43. van Kempen, L. C.; Ruiter, D. J.; van Muijen, G. N.; Coussens, L. M. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur. J. Cell Biol. 2003, 82 (11), 539-48.
44. Pasco, S.; Brassart, B.; Ramont, L.; Maquart, F. X.; Monboisse, J. C. Control of melanoma cell invasion by type IV collagen. Cancer Detect. Prev. 2005, 29 (3), 260-6.
45. Orimoto, A. M.; Neto, C. F.; Pimentel, E. R.; Sanches, J. A.; Sotto, M. N.; Akaishi, E.; Ruiz, I. R. High numbers of human skin cancers express MMP2 and several integrin genes. J. Cutan. Pathol. 2008, 35 (3), 285-91.
46. Humphries, J. D.; Byron, A.; Humphries, M. J. Integrin ligands at a glance. J. Cell Sci. 2006, 119 (Pt 19), 3901-3.
47. Kuratomi, Y.; Nomizu, M.; Tanaka, K.; Ponce, M. L.; Komiyama, S.; Kleinman, H. K.; Yamada, Y. Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells. Br. J. Cancer 2002, 86(7), 1169-73.
48. van Kempen, L. C.; Rijntjes, J.; Mamor-Cornelissen, I.; Vincent-Naulleau, S.; Gerritsen, M. J.; Ruiter, D. J.; van Dijk, M. C.; Geffrotin, C.; van Muijen, G. N. Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma. Int. J. Cancer 2008, 122 (5), 1019-29.
49. Daniels, K. J.; Boldt, H. C.; Martin, J. A.; Gardner, L. M.; Meyer, M.; Folberg, R. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab. Invest. 1996, 75 (1), 55-66.
50. Poser, I.; Bosserhoff, A. K. Transcription factors involved in development and progression of malignant melanoma. Histol. Histopathol. 2004, 19 (1), 173-88.
51. Zhuang, L.; Lee, C. S.; Scolyer, R. A.; McCarthy, S. W.; Zhang, X. D.; Thompson, J. F.; Hersey, P. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma. Mod. Pathol. 2007, 20 (4), 416-26.
52. Hoek, K. S. DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res. 2007, 20 (6), 466-84.
53. Eberle, J.; Kurbanov, B. M.; Hossini, A. M.; Trefzer, U.; Fecker, L. F. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches. Drug Resist. Update 2007, 10 (6), 218-34.
54. Songyang, Z.; Lu, K. P.; Kwon, Y. T.; Tsai, L. H.; Filhol, O.; Cochet, C.; Brickey, D. A.; Soderling, T. R.; Bartleson, C.; Graves, D. J.; DeMaggio, A. J.; Hoekstra, M. F.; Blenis, J.; Hunter, T.; Cantley, L. C. A structural basis for substrate specificities of protein Ser/ Thr kinases: primary sequence preference of casein kinases I and II, NIMA, Phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 1996, 16 (11), 6486-93.
55. Haass, N. K.; Smalley, K. S.; Li, L.; Herlyn, M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res. 2005, 18 (3), 150-9.
56. Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome. Science 2002, 298 (5600), 1912-34.
57. Budd, P. S.; Jackson, I. J. Structure of the mouse tyrosinase-related protein-2/dopachrome tautomerase (Tyrp2/Dct) gene and sequence of two novel slaty alleles. Genomics 1995, 29 (1), 35-43.
58. Marin, Y. E.; Namkoong, J.; Cohen-Solal, K.; Shin, S. S.; Martino, J. J.; Oka, M.; Chen, S. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell. Signalling 2006, 18 (8), 1279-86.
59. Brunner, E.; Ahrens, C. H.; Mohanty, S.; Baetschmann, H.; Loevenich, S.; Potthast, F.; Deutsch, E. W.; Panse, C.; de Lichtenberg, U.; Rinner, O.; Lee, H.; Pedrioli, P. G.; Malmstrom, J.; Koehler, K.; Schrimpf, S.; Krijgsveld, J.; Kregenow, F.; Heck, A. J.; Hafen, E.; Schlapbach, R.; Aebersold, R. A high-quality catalog of the Drosophila melanogaster proteome. Nat. Biotechnol. 2007, 25 (5), 576-83.
60. Medeiros, F.; Rigl, C. T.; erson, G. G.; Becker, S. H.; Hailing, K. C. Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch. Pathol. Lab. Med. 2007, 131 (12), 1805-16.
61. Larsen, M. R.; Thingholm, T. E.; Jensen, O. N.; Roepstorff, P.; Jorgensen, T. J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 2005, 4 (7), 873-86.
62. Beausoleil, S. A.; Jedrychowski, M.; Schwartz, D.; Elias, J. E.; Villen, J.; Li, J.; Cohn, M. A.; Cantley, L. C.; Gygi, S. P. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (33), 12130-5.
63. Bodenmiller, B.; Mueller, L. N.; Mueller, M.; Domon, B.; Aebersold, R. Reproducible isolation of distinct, overlapping segments of the phosphoproteome. Nat. Methods 2007, 4 (3), 231-7.
64. Thingholm, T. E.; Jensen, O. N.; Robinson, P. J.; Larsen, M. R. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 2008, 7 (4), 661-71.
65. 2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster. J. Proteome Res. 2008, 7 (2), 687-97.
66. Lasithiotakis, K. G.; Sinnberg, T. W.; Schittek, B.; Flaherty, K. T.; Kulms, D.; Maczey, E.; Garbe, C.; Meier, F. E. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. J. Invest. Dermatol. 2008, 128 (8), 2013-23.
67. Meier, F.; Schittek, B.; Busch, S.; Garbe, C.; Smalley, K.; Satyamoorthy, K.; Li, G.; Herlyn, M. The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front. Biosci. 2005, 10, 2986-3001.
68. Gingras, A. C.; Raught, B.; Sonenberg, N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 2001, 15 (7), 807-26.
69. Karbowniczek, M.; Spittle, C. S.; Morrison, T.; Wu, H.; Henske, E. P. mTOR is activated in the majority of malignant melanomas. J. Invest. Dermatol. 2008, 128 (4), 980-7.
70. Dan, H. C.; Sun, M.; Yang, L.; Feldman, R. I.; Sui, X. M.; Ou, C. C.; Nellist, M.; Yeung, R. S.; Halley, D. J.; Nicosia, S. V.; Pledger, W. J.; Cheng, J. Q. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 2002, 277 (38), 35364-70.
71. Cai, S. L.; Tee, A. R.; Short, J. D.; Bergeron, J. M.; Kim, J.; Shen, J.; Guo, R.; Johnson, C. L.; Kiguchi, K.; Walker, C. L. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 2006, 173 (2), 279-89.
72. Lopez-Bergami, P.; Huang, C.; Goydos, J. S.; Tip, D.; Bar-Eli, M.; Herlyn, M.; Smalley, K. S.; Mahale, A.; Eroshkin, A.; Aaronson, S.; Ronai, Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 2007, 11 (5), 447-60.
73. Madhunapantula, S. V.; Sharma, A.; Robertson, G. P. PRAS40 deregulates apoptosis in malignant melanoma. Cancer Res. 2007, 67 (8), 3626-36.
74. Zhou, X. M.; Liu, Y.; Payne, G.; Lutz, R. J.; Chittenden, T. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J. Biol. Chem. 2000, 275 (32), 25046-51.
75. Bischoff, J. R.; erson, L.; Zhu, Y.; Mossie, K.; Ng, L.; Souza, B.; Schryver, B.; Flanagan, P.; Clairvoyant, F.; Ginther, C.; Chan, C. S.; Novotny, M.; Slamon, D. J.; Plowman, G. D. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998, 17 (11), 3052-65.
76. Andrews, P. D.; Knatko, E.; Moore, W. J.; Swedlow, J. R. Mitotic mechanics: the auroras come into view. Curr. Opin. Cell Biol. 2003, 15 (6), 672-83.
77. Meraldi, P.; Honda, R.; Nigg, E. A. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev. 2004, 14 (1), 29-36.
78. Li, D.; Zhu, J.; Firozi, P. F.; Abbruzzese, J. L.; Evans, D. B.; Cleary, K.; Friess, H.; Sen, S. Overexpression of oncogenic STK15/BTAK/ Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 2003, 9 (3), 991-7.
79. Mountzios, G.; Terpos, E.; Dimopoulos, M. A. Aurora kinases as targets for cancer therapy. Cancer Treat. Rev. 2008, 34 (2), 175-82.
80. Higgs, R. E.; Knierman, M. D.; Gelfanova, V.; Butler, J. P.; Hale, J. E. Label-Free LC-MS Method for the Identification of Biomarkers. Methods Mol. Biol. 2007, 428, 209-30.
81. Bantscheff, M.; Schirle, M.; Sweetman, G.; Rick, J.; Kuster, B. Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 2007, 389 (4), 1017-31.
82. Navaza, A. P.; Encinar, J. R.; Carrascal, M.; Abian, J.; Sanz-Medel, A. Absolute and site-specific quantification of protein phosphorylation using integrated elemental and molecular mass spectrometry: its potential to assess phosphopeptide enrichment procedures. Anal. Chem. 2008, 80 (5), 1777-87.
83. Marcantonio, M.; Trost, M.; Courcelles, M.; Desjardins, M.; Thibault, P. Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling events of interferon-gamma-stimulated macrophages. Mol. Cell. Proteomics 2008, 7 (4), 645-60.
84. Peterson, R. T.; Beal, P. A.; Comb, M. J.; Schreiber, S. L. FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J. Biol. Chem. 2000, 275 (10), 7416-23.
85. Chiu, T.; Santiskulvong, C.; Rozengurt, E. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Am. J. Physiol.: Gastrointest. Liver Physiol. 2005, 288 (2), G182-94.
86. Shahbazian, D.; Roux, P. P.; Mieulet, V.; Cohen, M. S.; Raught, B.; Taunton, J.; Hershey, J. W.; Blenis, J.; Pende, M.; Sonenberg, N. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 2006, 25 (12), 2781-91.
87. Cauthron, R. D.; Carter, K. B.; Liauw, S.; Steinberg, R. A. Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase. Mol. Cell. Biol. 1998, 18 (3), 1416-23.